2160 — MicroPort CardioFlow Medtech Share Price
0.000.00%
Last trade - 00:00- HK$2.24bn
- HK$915.67m
- CNY361.57m
- 28
- 32
- 70
- 38
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 70.8 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.96 | ||
| Price to Tang. Book | 1.06 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.83 | ||
| EV to EBITDA | 10.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.87% | ||
| Return on Equity | -2.19% | ||
| Operating Margin | 5.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 103.93 | 200.81 | 251.03 | 336.21 | 361.56 | 506.55 | 687.08 | 75.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Microport Cardioflow Medtech Corp is a medical device company primarily engaged in the provision of total solutions to physicians and patients for the treatment of structural heart diseases. The Company’s main business is engaged in the research and development and commercialization of transcatheter and surgical solutions for structural heart diseases. The Company’s pipelines include transcatheter aortic heart valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) product, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products and procedural accessories. The Company conducts its business in the domestic and overseas markets.
Directors
- Qiyi Luo NEC (59)
- Guoming Chen PRE (36)
- Guojia Wu VPR (47)
- Luying Yan VPR (39)
- Lok Yee Chan SEC (31)
- Xiangmei Li SEC
- Xia Wu NED (39)
- Junjie Zhang NED (43)
- Jonathan Chou NID (57)
- Jiandong Ding NID (56)
- Zhixiang Sun NID (53)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 10th, 2019
- Public Since
- February 4th, 2021
- No. of Employees
- 430
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,412,593,000
- Address
- No. 1601 Zhangdong Road, SHANGHAI
- Web
- https://www.cardioflowmedtech.com/
- Phone
- Auditors
- KPMG CPA
Upcoming Events for 2160
Half Year 2025 Microport Cardioflow Medtech Corp Earnings Release
Similar to 2160
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the MicroPort CardioFlow Medtech share price?
As of Today at 19:47 UTC, shares in MicroPort CardioFlow Medtech are trading at HK$0.93. This share price information is delayed by 15 minutes.
How has the MicroPort CardioFlow Medtech share price performed this year?
Shares in MicroPort CardioFlow Medtech last closed at HK$0.93 and the price had moved by -5.1% over the past 365 days. In terms of relative price strength the MicroPort CardioFlow Medtech share price has underperformed the FTSE Developed Asia Pacific Index by -4.02% over the past year.
What are the analyst and broker recommendations for MicroPort CardioFlow Medtech?
The overall consensus recommendation for MicroPort CardioFlow Medtech is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the MicroPort CardioFlow Medtech dividend yield?
MicroPort CardioFlow Medtech does not currently pay a dividend.
Does MicroPort CardioFlow Medtech pay a dividend?
MicroPort CardioFlow Medtech does not currently pay a dividend.
When does MicroPort CardioFlow Medtech next pay dividends?
MicroPort CardioFlow Medtech does not currently pay a dividend.
How do I buy MicroPort CardioFlow Medtech shares?
To buy shares in MicroPort CardioFlow Medtech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MicroPort CardioFlow Medtech?
As of the previous close price of HK$0.93, shares in MicroPort CardioFlow Medtech had a market capitalisation of HK$2.24bn.
Where are MicroPort CardioFlow Medtech shares listed?
Here are the trading details for MicroPort CardioFlow Medtech:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2160
What kind of share is MicroPort CardioFlow Medtech?
Based on an overall assessment of its quality, value and momentum MicroPort CardioFlow Medtech is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MicroPort CardioFlow Medtech share price forecast for 2025?
The analyst consensus target price for shares in MicroPort CardioFlow Medtech is HK$1.50. That is 61.27% above the last closing price of HK$0.93.
Analysts covering MicroPort CardioFlow Medtech currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.00 for the next financial year.
Find out moreWhat is the trend in the MicroPort CardioFlow Medtech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MicroPort CardioFlow Medtech. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +31.39%.
As of the last closing price of HK$0.93, shares in MicroPort CardioFlow Medtech were trading +17.09% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MicroPort CardioFlow Medtech PE Ratio?
The MicroPort CardioFlow Medtech PE ratio based on its reported earnings over the past 12 months is 70.8. The shares last closed at HK$0.93.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MicroPort CardioFlow Medtech?
MicroPort CardioFlow Medtech's management team is headed by:
- Qiyi Luo - NEC
- Guoming Chen - PRE
- Guojia Wu - VPR
- Luying Yan - VPR
- Lok Yee Chan - SEC
- Xiangmei Li - SEC
- Xia Wu - NED
- Junjie Zhang - NED
- Jonathan Chou - NID
- Jiandong Ding - NID
- Zhixiang Sun - NID